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The aim of this study was to evaluate the protective eﬀects of Ginkgo biloba (GB) against testicular damage and oxidative stress as
well as caudal sperm indices in a cisplatin- (CIS-) induced rodent model. Adult male Wistar rats were given vehicle, single i.p. dose
ofCISalone(10mg/kg),GBalone(200mgg/kgeverydayforﬁvedays),orsingledoseofCISfollowedbyGB(50,100,or200mg/kg
everydayforﬁvedays).Onday6,aftertheﬁrstdrugtreatmentoxidativeandapoptotictesticulartoxicitywasevaluated.CIS-treated
ratsdisplayeddecreasedweightsoftestesandepididymisaswellascaudalspermcountandmotility.Thisreproductivetoxicitywas
accompaniedwithincreasedgerm-celldegenerationinseminiferoustubulesandincreasedgerm-cellapoptosis,increasedtesticular
MDA levels and MPO activity, and decreased SOD and CAT activities in testes. Intensive expressions of COX-2, iNOS, and NF-κB
p65 in testicular tissues were detected in CIS-treated group. Oral GB administrations at all doses to CIS-treated rats eﬀectively
alleviated all of the CIS-induced toxicity in reproductive system. The present results provide further insights into the mechanisms
of protection against CIS-induced reproductive toxicity and conﬁrm the essential antioxidant potential of a GB extract.
1.Introduction
Chemotherapy has emerged as an eﬃcient mode of treat-
ment for various carcinogenesis. Eﬀective systemic drugs
are increasingly used to treat cancer patients. Cisplatin
(cis-diamminedichloroplatinum-II, CIS), one of the most
eﬀective and widely prescribed anticancer drugs, is still used
in the treatment of many types of solid tumors including
testicular cancer [1, 2]. It has been proven highly eﬀective
in curing testicular cancer in combination with other drugs
even at an advanced stage of the disease [3]. CIS kills cancer
cells by forming covalent adducts with the cellular DNA
molecules and thereby terminating the vital processes like
replication and transcription and inducing apoptosis [4].
In spite of its high eﬃciency in the treatment of testicular
cancer, CIS has severe adverse eﬀects on spermatogenesis
and even leads to a condition of azoospermia [5, 6]. Sper-
matogenesis is a complex process which is highly inﬂuenced
by hormone molecules and temperature and involves an
array of testicular cells such as germ cells, Sertoli cells,
Leydig cells, and peritubular cells [7, 8]. Acute exposure
to antineoplastic agents like CIS has shown an increase in
the frequency of germ-cell apoptosis [9, 10] in experimental
animals. Moreover, it can also lead to decreased reproductive
organweights,azoospermia,anddegeneratedspermatogenic
cells[11,12].ThemolecularmechanismbywhichCIScauses
reproductive toxicity and germ-cell apoptosis remains to
be elucidated. However, pathogenesis of testicular damage
followed by CIS exposure is generally ascribed to oxidative
stress mediated by increased free radical generation and
depletion of antioxidants. Free radicals have been reported
to mediate reactions responsible for a wide range of CIS-
induced side eﬀects [9, 11]. Consequently, antioxidants have
beenshowntoprotectnonmalignantcellsandorgansagainst
damage by CIS [9, 11, 13].
Ginkgo biloba (GB) has been used in traditional Chinese
medicine for about 5000 years, and it is one of the herbal
drugs that is used widely according to its antioxidant2 Journal of Biomedicine and Biotechnology
properties and ability to modify vasomotor function, aﬀect
ion channels to inhibit activation of platelets and smooth
muscle cells [14], stimulate neurotransmitters [15], decrease
adhesion of blood cells to endothelium, and modify signal
transduction [14]. In addition, GB has been used in the
treatment of Alzheimer’s disease and cognitive impairment.
The major GB components are ﬂavonoglycosides and ter-
penelactones.GBextractwasalsoreportedformanydecades
t oi n c r e a s ep e r i p h e r a la n dc e r e b r a lb l o o dﬂ o wa sw e l la s
for the treatment of dementia [16]. Furthermore, extract of
GB leaves has been shown to have a strong antioxidant that
directly scavenges ROS [15].
Inducible nitric oxide synthase (iNOS) is responsible for
the formation of high levels of nitric oxide (NO) under
oxidative stress resulting in autocytotoxicity [17]. Previous
studies have shown that NO along with ROS triggers
cell death and the oxidation products of NO can induce
lipid peroxidation [18–20]. Transcription factors like NF-
kB stimulated under oxidative stress can also induce iNOS
expression [21]. Inhibiting NF-kB and thereby iNOS using
antioxidants has already proved to be eﬀective in attenuating
the CIS-induced testicular injury [20]. Cyclooxygenase-
(COX)-2 is an inducible form of COX which plays a
physiological role in inﬂammation and tumor proliferation
[22]. COX-2 selective inhibitors have been found to be
eﬀective in ameliorating CIS-induced nephrotoxicity in rats
[23].
To determine whether or not standardized GB extract
could attenuate toxicity and oxidative stress in testicular
tissues, this study was designed to assess the preventive role
of GB extract on the biochemistry and pathology of CIS-
induced testicular abnormalities in rats. The modulating
roles of NF-kB, iNOS, and COX-2 in CIS-induced oxidative
testicular injury induced were also evaluated in the present
work.
2.MaterialsandMethods
2.1. Animals. Sixty adult male Wistar rats (8 weeks old
weighing 120–240g) were obtained from the Animal House,
United Arab Emirates University,UAE. They were kept in
polycarbonate cages and supplied with standard pellet diet
and tap water under a 12h light/dark cycle and room
temperature of 22–24◦C. This study was approved by the
Animal Ethics Committee, UAE University,UAE.
2.2. Chemicals and Plant. CIS was purchased from Hos-
pira UK Limited, Warwickshire, UK. GB-leaf extract was
obtained from General Nutrition Corporation, Pittsburgh,
USA. Thiobarbituric acid, 1,1,3,3-tetramethoxy-propan,
phosphoric acid, sulfuric acid and hydrogen peroxide were
obtained from Sigma Chemical (St. Louis, MO, USA). The
GB extract is standardized to Ginkgo ﬂavonoglycosides
(24%) and terpene lactones (6%) which represent the major
active contents of GB.
2.3. Experimental Protocol. Rats were divided into six groups
(n = 10). The groups were treated as follows: control
or normal (N) received water (5mL/kg body weight) for
ﬁve days and a single intraperitoneal injection (i.p.) of
saline on the ﬁrst day (5mL/kg body weight). Same dose
volume (5mL) was used for all other groups; GB alone
( G B )r e c e i v e do n l y2 0 0m g / k gb o d yw e i g h to fG Bw a t e r
extract; CIS alone (CIS) where rats were given CIS as single
dose (10mg/kg; i.p.) on the ﬁrst day of treatment, a dose
that induced testicular toxicity in rats [24]. Rats of the
protective groups (CIS+L: 50mg/kg GB; CIS+M;100 mg/kg
GB; CIS+H: 200mg/kg GB) received GB for ﬁve days 1h
after a single dose of CIS on the ﬁrst day of treatment. GB
was dissolved in water and administrated orally at three-
dose levels 50 (low dose; L), 100 (medium dose; M), and 200
(highdose;H)mg/kgbodyweight.DosesofGBwereselected
based on previously reported pharmacological properties of
this plant [19]. Five days after the administration of CIS or
GB, the rats were sacriﬁced after being anesthetized with
diethyl ether. Rats were weighed in regularly, and their testes
and epididymis were dissected out and weighed.
2.4. Sperm Motility and Count. Total sperm number was
determined by using a Neubauer hemocytometer. Cauda
epididymis was dissected out, weighed, immediately minced
in 5mls of physiological saline, and then incubated at 37◦C
for 30 minutes to allow sperms to leave the epididymal
tubules. The percentage of motile sperm was recorded from
left cauda epididymis using a phase contrast microscope at
400x magniﬁcation. The total number of sperm per gram of
cauda (of the right side) was then calculated.
2.5.Biochemistry. Testeswerehomogenizedseparatelyinice-
cold Tris-KCl buﬀer (150mmol/L). The w/v ratio of the
tissuetothehomogenizationbuﬀerwas(1:10w/v).Aliquots
were prepared and used for determination of diﬀerent
biochemical markers.
Supernatants were collected, and assays for lipid per-
oxidation and CAT were performed. Determination of
MDA in testicular homogenate is based on its reaction
with thiobarbituric acid (TBA) to form a pink complex
with an absorption maximum at 535nm. CAT activity was
determined by measuring the exponential disappearance of
H2O2 at 240nm and was expressed in units/mg of protein
as described by Aebi [25], and total protein was estimated
by Lowry’s method. Superoxide dismutase (SOD) activity in
testicular tissues was determined according to the method
described in [26]. This method is based on the ability of
SOD to inhibit the auto-oxidation of pyrogallol at alkaline
pH. Myeloperoxidase (MPO)activity in testicular tissues was
determined as described in [27]. One unit of MPO activity is
deﬁned as that which degrades 1μmol H2O2/min at 25◦C.
2.6. Histology. For the histological examinations, small
pieces of testis were ﬁxed in 10% neutral phosphate-buﬀered
formalin, and the hydrated 5μm thick sections were stained
with hematoxylin and eosin. Sections were examined under
a Leica DMRB/E light microscope (Heerbrugg, Switzerland).
2.7. Immunohistochemistry. Terminal deoxynucleotidyl
transferase-mediated triphosphate nick-end labelingJournal of Biomedicine and Biotechnology 3
Figure 1: Photomicrograph of cross-sections of the testes of control (N), GB alone (GB), CIS alone (CIS), and the three GB-protected
rats (CIS+L: 50mg/kg GB; CIS+M: 100mg/kg GB; CIS+H: 200mg/kg GB). Testes of control and GB alone treated groups show normal
arrangement of germ cells and Sertoli cells. However, CIS-treated testes show severely damaged seminiferous tubules. Rats protected with
GB were less aﬀected by CIS (H & E 200x).
(TUNEL) technique was used to determine apoptosis.
Deparaﬃnized and gradually hydrated, 4μm thick sections
of testes have been used to assess apoptosis, and TUNEL
was performed using the ApopTag Plus Peroxidase in
situ Apoptosis Detection Kit (Serologicals Corporation,
Norcross, GA, USA). The principle of the method is based
on the catalytic activity of terminal deoxynucleotidyl
transferase which adds digoxigenin nucleotides to the
terminal 3 -OH of DNA molecule and thereby detecting
the DNA fragmentation associated with apoptosis. Further
immunohistochemical analysis was done using sequential
mountedsectionsofthespecimen.Initiallytheantigenswere4 Journal of Biomedicine and Biotechnology
Figure 2: Photomicrograph of cross-sections of the testes of control (N), GB alone (GB), CIS alone (CIS), and the three GB-protected
rats (CIS+L: 50mg/kg GB; CIS+M: 100mg/kg GB; CIS+H: 200mg/kg GB). Testes of control and GB alone treated groups show normal
arrangement of germ cells and Sertoli cells. However, CIS-treated testes show extensive atrophy of seminiferous tubules and degenerations of
g e r mc e l l s .R a t sp r o t e c t e dw i t hd i ﬀerent GB doses clearly show less degeneration of some tubules and irregular derangement of some germ
cells (H & E 400x).
revealed by incubating the sections in a heated water bath
for 15 minutes followed by the blocking of the endogenous
peroxidase activity with 0.3% H2O2 in methanol. Anti-rat
primary antibodies (1:100 dilution) for COX-2 (Clone SP-
21), iNOS (Ab-1) and NF-kB p65 (Rel A, Ab-1) from rabbit
were obtained from Thermo Fisher Scientiﬁc (Anatomical
Pathology, Fremont, USA). The sections were ﬁrst incubated
in primary antibodies overnight at 4◦C. After overnight
incubation, the slides were washed with PBS, and the
sections were incubated with polyvalent biotin-labeled
goat anti-rabbit secondary antibody (1:200 dilution) for 10
minutesatroomtemperature.ThesectionswerethenstainedJournal of Biomedicine and Biotechnology 5
Table 1: The eﬀe c to ft h eGB extracts on testicular epididymal weights and on epididymal sperm count, motility, and abnormality in CIS-
treated rats.
Parameters N GB CIS CIS+L CIS+M CIS+H
Testes weight (gm) 3.51 ±0.06 3.59 ±0.11 2.99 ±0.12
∗ 3.49 ± 0.08# 3.52 ±0.18# 3.65 ±0.13###
Epididymis weight (gm) 1.64 ±0.06 1.53 ±0.06 1.30 ±0.04
∗∗ 1.38 ±0.05
∗∗ 1.46 ±0.08 1.44 ±0.05
Sperm (count.106)/gm of cauda 131.0 ±7.73 134.9 ±11.64 83.94 ±8.03
∗ 94.50 ±20.25 94.67 ±7.77 118.78 ±8.78
Sperm motility (%) 79.125 ±3.34 68.12 ±2.64 28.125±1.52
∗∗∗ 54.0±5.59
∗∗∗### 49.0±3.83
∗∗∗### 50.0 ±4.2
∗∗∗###
∗P < 0.05 versus control, #P < 0.05 versus CIS, ∗∗P < 0.01 versus control, ###P < 0.001 versus CIS, ∗∗∗P < 0.001 versus control.
Table 2: The eﬀe c to ft h eGB extracts on oxidative stress parameters associated with CIS treatment in testicular tissues of rats.
Parameters N GB CIS CIS+L CIS+M CIS+H
MDA (nmol/mg protein) 0.97 ±0.03 0.86 ±0.08 1.2 ±0.08
∗∗∗ 1.0 ±0.07c 0.84 ±0.06a 0.98 ±0.05c
M P O( m u / m gp r o t e i n ) 1 6 .92 ±0.34 17.13 ±0.31 24.65 ±2.2
∗∗∗ 18.88 ±0.93b 19.69 ±1.54c 16.93 ±0.59c
CAT (u/mg protein) 146.79 ±2.9 144.07 ±2.03 84.89 ±3.24
∗∗∗ 127.9 ±3.9
∗∗∗a 118.0±3.64
∗∗∗a 134.4 ±1.88
∗a
SOD (u/mg protein) 3.37 ±0.02 3.37 ±0.01 3.62 ±0.05
∗∗∗ 3.26 ±0.08a 3.16 ±0.09a 3.25 ±0.06a
Values are expressed as mean ± SEM of eight rats per group. Concentration is expressed as nmol/mg protein for MDA. Activity is expressed as unit/mg protein
for CAT and SOD. Activity is expressed as m unit/mg protein for MPO. Signiﬁcance was determined by one-way analysis of variance followed by Dennett’s
t-test: ∗P < 0.05; ∗∗∗P < 0.001 versus control. cP < 0.05; bP < 0.01; aP < 0.001 versus CIS group.
using Universal LSAB plus kit and a DAB plus substrate
kit as the chromogen followed by a light counterstaining
with hematoxylin. Tissue images were captured by optical
microscopy (Olympus DP71).
2.8. Statistical Analysis. Data are expressed as group mean ±
SE. The statistical analysis was carried out using ANOVA,
with SPSS version 10 (SPSS, Chicago, IL, USA). ANOVA was
carried out to detect the diﬀerences between all the various
groups. When signiﬁcant diﬀerences were detected, analysis
of a diﬀerence between the means of the treated and control
groups was carried out using Dunnett’s t-test.
3. Results
3.1. Histopathological Eﬀects. Testicular tissues in the con-
trol group showed normal arrangement of germinal and
Sertoli cells without any histopathological lesions. CIS-
treated groups showed moderate to severe testicular atrophy
with severe cellular disorganization and degeneration in
seminiferous tubules (Figures 1 and 2) and interstitium. CIS
treatment also induced depletion of Leydig cells between
the tubules. Degenerated Sertoli cells were also observed
in the lumen. Animals pretreated with GB showed normal
testicular morphology with irregular arrangement of germ
cells and slight degeneration of seminiferous epithelium and
shedding of germ cells in some tubules.
3.2. Eﬀects on Weights of Testes and Epididymis. The weights
of testes and epididymis in rats after CIS administration
were found to be signiﬁcantly decreased, compared with the
controlgroup(Table1).Nosigniﬁcantchangesintheweights
of testes and epididymis were found in rats treated with GB
alone. However, GB caused signiﬁcant improvements in the
weights of testes (P<0.05 and P<0.001) and showed some
recovery of epididymal weights of rats of all protected groups
(Table 1). The administration of CIS alone or with prior GB
administrationsatallthreetesteddosesdidnotalterthebody
weight of the animals (data not shown).
3.3. Eﬀects on Sperm Motility and Count. After CIS was
administered, the caudal sperm count (P<0.05) and
motility decreased signiﬁcantly (P<0.001). Administration
of GB attenuated the depletion of sperm counts where
therewasnosigniﬁcantdiﬀerencebetweenpreventivegroups
and the control. However, all doses of GB signiﬁcantly
(P<0.001) increased the CIS-induced decreases in sperm
motility. Administration of GB attenuated the CIS-induced
decrease of sperm count. Eﬀect of GB extract on caudal
sperm count and motility is given in Table 1.
3.4. Eﬀects on Oxidative Stress on Testicular Tissues. CIS-
intoxicated rats, testicular MDA levels, and MPO activity
were signiﬁcantly (P<0.001) increased, and SOD and
CAT activities were signiﬁcantly (P<0.001) decreased
indicating the potent oxidative action of CIS on testicular
tissues. Coadministration of GB with CIS neutralized these
abnormalities in levels of MDA, SOD, CAT, and MPO
reﬂecting the eﬀect of GB against CIS-induced oxidative
stress in testes (Table 2).
3.5. Immunohistochemistry. Apoptotic cell death in seminif-
eroustubuleswasassessedusingTUNELtechnique.TUNEL-
positive nuclei were observed in brown color in the semi-
niferous tubules of control and CIS-treated rats (Figure 3).
However, testicular tissues exposed to CIS contained high
frequency of TUNEL-positive germ cells in contrast to those
treated with GB.6 Journal of Biomedicine and Biotechnology
Figure 3: Terminal deoxynucleotidyl transferase-mediated triphosphate nick-end labeling-(TUNEL-) positive cells in seminiferous tubules
of rats treated with vehicle (N), GB alone (GB), CIS alone (CIS), and the three GB-protected rats (CIS+L: 50mg/kg GB; CIS+M: 100mg/kg
GB; CIS+H: 200mg/kg GB). Photomicrographs show variable levels of apoptosis in diﬀerent experimental groups Brown staining indicates
TUNEL-positive cells. Tissues were counterstained with hematoxylin, 400x.
Immunohistochemical ﬁndings showed an increase in
the expression of COX-2 (Figure 4), iNOS (Figure 5), and
NF-kB (Figure 6) after CIS administration. Coadministra-
tion with GB extract markedly reduced the CIS-induced
overexpression of COX-2, iNOS, and NF-kB which shows no
signiﬁcant variation when compared to the control.
4. Discussion
CIS is one of the leading anticancer drugs in the chemother-
apytreatmentofvarietyofcancertypes;itinducesatesticular
damage, sperm dysfunction, germ-cell apoptosis, and abnor-
malities in Leydig cells in rats [28–30]. Our previous studyJournal of Biomedicine and Biotechnology 7
Figure 4: Immunohistochemical staining showing COX-2 expression in control (N), GB alone (GB), CIS alone (CIS), and the three GB-
protected rats (CIS+L: 50mg/kg GB; CIS+M: 100mg/kg GB; CIS+H: 200mg/kg GB). Photomicrographs show variable levels of COX-
2 expression in diﬀerent experimental groups. Brown staining indicates COX-2 expression. CIS group show increased levels of COX-2
expression compared to N and all three GB-protected groups. Tissues were counterstained with hematoxylin, 400x.
has shown that CIS impaired rat testicular structure through
inﬂicting oxidative stress and inducing cell apoptosis [9, 24].
Current data shows that pretreatment with GB extract (24%
Ginkgo biloba ﬂavonoglycoside, 6% terpene lactones) oﬀers
protection against the histopathological lesions induced by
CIS. Also the increase in apoptotic changes induced by CIS
has been found to be decreased in those rats which were
treated with diﬀerent doses of GB extract.
These testicular protective eﬀects of GB were accompa-
nied with restoration of the normal level of CAT, SOD, and8 Journal of Biomedicine and Biotechnology
Figure 5: Immunohistochemical staining showing iNOS expression in control (N), GB alone (GB), CIS alone (CIS), and the three GB-
protected rats (CIS+L: 50mg/kg GB; CIS+M: 100mg/kg GB; CIS+H: 200mg/kg GB). Photomicrographs show variable levels of iNOS
expressionindiﬀerentexperimentalgroups.BrownstainingindicatesiNOSexpression.CISgroupshowsincreasedlevelsofiNOSexpression
compared to N and the GB-protected groups. Tissues were counterstained with hematoxylin, 400x.
MPO in CIS-treated animals. Normal physiological levels
of NF-kB, iNOS, and COX-2 expression have also been
maintained by the Coadministration of GB extract.
Recently studies have shown that herbal plants extracts
with protective eﬀects against CIS-induced reproductive
damages are due to the presence of antioxidant agents [31].
The present investigation illustrates that the administration
of GB extract restores the control values of oxidative stress
markers. This study provides evidence that the antioxidative
properties of GB may contribute to its ability to restore the
level of SOD and CAT enzyme and to reduce the MDA
content as well as MPO levels in the testicular tissues. The
antioxidant activity of GB could be attributed to its active
components, namely, ﬂavonoglycoside and terpene lactones.Journal of Biomedicine and Biotechnology 9
Figure 6: Immunohistochemical staining showing NF-kB expression in control (N), GB alone (GB), CIS alone (CIS), and the three GB-
protected rats (CIS+L: 50mg/kg GB; CIS+M: 100mg/kg GB; CIS+H: 200mg/kg GB). Photomicrographs show variable levels of NF-kB
expression in diﬀerent experimental groups. Brown staining indicates NF-kB expression. CIS-treated rats show increased NF-kB levels
compared to N and all other GB-protected groups. Tissues were counterstained with hematoxylin, 400x.
The current study also showed an elevated level of NF-
kB, iNOS, and COX-2 as a result of CIS treatment. Oxidative
stress and subsequent activation of signaling kinases are
known to stimulate transcription factors, like NF-kB [32–
34]. NF-kB function as a link between oxidative damage
andinﬂammation.Thisfactortransducesoxidativestimulito
nucleus to modulate the expression of many genes involved
in inﬂammatory responses [35, 36] .O n es u c hg e n ei st h a tf o r
iNOS, it is generally thought that excessive NO production
d u et oe l e v a t e di N O Sc a nc a u s ec y t o t o x i ce ﬀects and has
the potential to induce germ-cell apoptosis [20, 37, 38].
According to the data obtained, GB extract reduces the
formation of NF-kB and iNOS to the normal level as
in untreated rats. Rise in COX-2 levels induced by CIS,10 Journal of Biomedicine and Biotechnology
observed during the immunohistochemical analysis, seems
to be eﬃciently reducing in the GB-treated animals.
In conclusion, this study provides evidence that CIS
adversely damages testicular tissue and signiﬁcantly reduces
sperm production through increasing oxidative stress and
inducing apoptosis and upregulations of NF-kB, iNOS, and
COX-2, while GB treatment eﬀectively attenuated these
oxidative and apoptosis actions of CIS in testes.
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